Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Retatrutide is an investigational triple agonist peptide currently under clinical development, targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
Purity should be 98 percent or higher for research-grade peptides
All combinations are medically supervised and customized to maximize fat loss and maintain energy and muscle
A 2019 study on NAFLD/NASH found oral supplementation at 300 mg daily effectively prevented disease progression
US$ 28.83
US$ 27.94
US$ 20.00
US$ 23.27
US$ 23.69
US$ 27.19
US$ 23.37
US$ 25.63
